2024 year in review
Colorectal Cancer Awareness Month
Ovarian Awareness Month
National No Smoking Day
The UCD Cancer Trials Cluster has expended to include three new members!
Read about updates on: 1. The results of a phase 1 trial for advanced melanoma 2. The results of the PENELOPE-B trial for preventing breast cancer relapse 3. The results of a study aiming to preduct treatment response in breast cancer
Our Director meets with An Taoiseach Simon Harris and CEO of the Irish Cancer Society.
Learn about sarcomas and the trial opportunities we have!
The Irish Cancer Society has published their Budget 2025 Submission, with input from Director of the UCD Cancer Trials Cluster.
Read about updates on: a pragmatic trial to reduce treatment-related toxicities in prostate cancer; better understand the experiences of the prostate cancer diagnostic pathway; and fertility preservation in women with breast cancer.
Find out what happened at the UCD Cancer Research Symposium, which took place 7th June 2024 at UCD Conway
May marks Skin Cancer Awareness month. Read about Skin cancer in Ireland and the role of the UCD Cancer Trials Cluster in developing new treatments.
Read about updates on: an intervention for cancer patients experiencing menopause symptoms; the results of the NATALEE trial; and the results of a treatment development study for Cutaneous T-Cell Lymphoma.
The first results of DESTINY-12 have been published, examining the effectiveness of trastuzumab deruxtecan (T-DXd) in people with advanced HER2-positive breast cancer, particularly in patients with brain metastases.
Two new studies open exploring treatments for venous thromboembolism and the language used to describe people with cancer.
Two new trials for people with metastatic colorectal cancer and non-small cell lung cancer.
The 16th International Symposium on Translational Research in Oncology will take place 27th-29th September 2023.
The UCD Cancer Trials Cluster is the highest recruiter in Ireland.
Siobhan Gaynor, who is living with metastatic breast cancer, has just launched a study with Cancer Trials Ireland.
The OASIS-4 trial has opened at St Vincent's and the Mater Hospitals to treat hot flashes in women with hormone-receptor positive (HR-positive) breast cancer.
An outstanding programme of speakers organised by the Cancer Clinical Research Trust
.png)
 (7).png)
 (6).png)
 (1).png)
.png)
.png)
.png)
.png)
.jpg)
